The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
from NDTV News - Special https://ift.tt/2EntxSq
Subscribe to:
Post Comments (Atom)
Structured tender model for shipbuilding: Govt aims tech transfer, local manufacturing
India is boosting its shipbuilding capabilities by adopting a "structured tender" approach for specialized vessels like gas and oi...
-
China has emerged as a significant player in AI foundation models with DeepSeek, creating powerful AI models at lower costs than the West. T...
-
Nigeria's President Buhari on Sunday denied claims that he had died and been replaced by a Sudanese impostor, breaking his silence on a ...
-
Meng Wanzhou, the high-profile top executive of telecom giant Huawei who was detained in Canada for over three years, received a hero's ...
No comments:
Post a Comment